Continuous fever monitoring for children on cancer treatment
Part of Blood & lymphatic clinical trials.
This study tests a way to continuously monitor fever in children getting cancer treatment that suppresses the bone marrow. It may help doctors detect fever episodes earlier and respond faster during periods when infection risk is higher.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a child aged 1 month to under 18 years at the start of the study
- Be receiving cancer treatment expected to last at least 2 months, or have had intensive chemo followed by stem cell transplant
- Be on a treatment plan that lowers bone marrow activity (so infection risk may be higher)
- Have a guardian/parent able to give written consent for participation (and assent when appropriate)
- Have no skin problem on the local area that would prevent wearing the monitoring device
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how long antibiotics should be given to cancer patients with fever and very low white blood cell counts after finding a certain type of bacteria (Gram-negative) in their blood. The goal is to find the best treatment duration to help patients recover without complications.
This study tests whether adjusting antibiotic doses based on how fast your kidneys clear the medicine can better treat infections in children with cancer who have a fever and low white blood cells (neutropenia). It aims to improve recovery and reduce side effects.
This trial tests a home monitoring device to help families of children with cancer who are at risk of infection from low white blood cells. The device may help catch problems early and reduce hospital visits.
This trial tests a smartphone app and wearable sensor to track your temperature after leaving the hospital, alerting you or your doctors if a fever develops. It aims to catch fevers early so you can get faster care.
This trial compares stopping antibiotics early (after fever resolves) versus continuing them as usual in adults with blood cancers who develop fever during treatment. It aims to find the best timing to reduce unnecessary antibiotic use.
This trial tests a wearable device that continuously measures your body temperature while you are in the hospital. It may help doctors track fever or temperature changes caused by infections or other illnesses.
Hear when a new Pediatric Oncology Patients With Risk for Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.